Glibornuride: Difference between revisions

	WikiDoc Resources for Glibornuride
Articles
Most recent articles on Glibornuride Most cited articles on Glibornuride Review articles on Glibornuride Articles on Glibornuride in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Glibornuride Images of Glibornuride Photos of Glibornuride Podcasts & MP3s on Glibornuride Videos on Glibornuride
Evidence Based Medicine
Cochrane Collaboration on Glibornuride Bandolier on Glibornuride TRIP on Glibornuride
Clinical Trials
Ongoing Trials on Glibornuride at Clinical Trials.gov Trial results on Glibornuride Clinical Trials on Glibornuride at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Glibornuride NICE Guidance on Glibornuride NHS PRODIGY Guidance FDA on Glibornuride CDC on Glibornuride
Books
Books on Glibornuride
News
Glibornuride in the news Be alerted to news on Glibornuride News trends on Glibornuride
Commentary
Blogs on Glibornuride
Definitions
Definitions of Glibornuride
Patient Resources / Community
Patient resources on Glibornuride Discussion groups on Glibornuride Patient Handouts on Glibornuride Directions to Hospitals Treating Glibornuride Risk calculators and risk factors for Glibornuride
Healthcare Provider Resources
Symptoms of Glibornuride Causes & Risk Factors for Glibornuride Diagnostic studies for Glibornuride Treatment of Glibornuride
Continuing Medical Education (CME)
CME Programs on Glibornuride
International
Glibornuride en Espanol Glibornuride en Francais
Business
Glibornuride in the Marketplace Patents on Glibornuride
Experimental / Informatics
List of terms related to Glibornuride

Glibornuride
Names
	IUPAC name 1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
Identifiers
CAS Number	26944-48-9 ;
3D model (JSmol)	Interactive image;
DrugBank	DB08962 ;
ECHA InfoCard	Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG	D02427 ;
PubChem CID	33649;
	SMILES CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2C3CCC(C2O)(C3(C)C)C;
Properties
Chemical formula	C18H26N2O4S
Molar mass	366.48 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

← Older edit

VisualWikitext

Latest revision as of 16:25, 20 August 2015

Template:Chembox E number

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.^[1]

References

↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.

[1] Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.

[1]

@@ Line 1: / Line 1: @@
-<!--Drug box 2-->
+{{chembox
-|drugBox2=[[File:Glibornuride.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
+| Verifiedfields = changed
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = VP83E7434R
+| verifiedrevid = 444003955
+|ImageFile=Glibornuride.png
+|ImageSize=200px
+|IUPACName=1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
+|OtherNames=
+|Section1={{Chembox Identifiers
+| CASNo_Ref = {{cascite|correct|??}}
+| CASNo=26944-48-9
+| PubChem=33649
+| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
+| DrugBank = DB08962
+| KEGG_Ref = {{keggcite|correct|kegg}}
+| KEGG = D02427
+| SMILES=CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2C3CCC(C2O)(C3(C)C)C
+| ATCCode_prefix = A10
+| ATCCode_suffix = BB04
+  }}
+|Section2={{Chembox Properties
+|  Formula=C<sub>18</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>S
+|  MolarMass=366.48 g/mol
+|  Appearance=
+|  Density=
+|  MeltingPt=
+|  BoilingPt=
+|  Solubility=
+  }}
+|Section3={{Chembox Hazards
+|  MainHazards=
+|  FlashPt=
+|  Autoignition=
+  }}
+}}
 __NOTOC__
 {{SI}}
@@ Line 13: / Line 47: @@
 {{Oral hypoglycemics and insulin analogs}}
+[[Category:Sulfonylureas]]
 [[Category:Alcohols]]
 [[Category:Drug]]
-[[Category:Sulfonylureas]]

v t e Oral antidiabetic drugs and Insulin analogs (A10)
Biguanides	Metformin
Sulfonylureas	Chlorpropamide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, Tolbutamide
Alpha-glucosidase inhibitors	Acarbose, Miglitol, Voglibose
Thiazolidinediones (TZD)	Pioglitazone, Rivoglitazone^†, Rosiglitazone, Troglitazone^‡
Meglitinides	Nateglinide, Repaglinide, Mitiglinide
Dipeptidyl peptidase-4 (DPP-4) inhibitors	Alogliptin^†, Saxagliptin^†, Sitagliptin, Vildagliptin, Linagliptin^†
Glucagon-like peptide-1 analog	Exenatide, Liraglutide^†, Albiglutide^†
Amylin analog	Pramlintide
Insulin analogs	fast acting (Insulin lispro, Insulin aspart, Insulin glulisine), long acting (Insulin glargine, Insulin detemir)
Dual PPAR agonists	Aleglitazar^†, Muraglitazar^§, Tesaglitazar^§
SGLT2 inhibitor	Dapagliflozin^†, Remogliflozin^†
^†Undergoing clinical trials. ^‡ Withdrawn from market. ^§Development halted.

Glibornuride: Difference between revisions

Latest revision as of 16:25, 20 August 2015

Overview

References

Navigation menu

Search